home / stock / rgnx / rgnx message board
Subject | By | Source | When |
---|---|---|---|
36M share trading float. | crudeoil24 | investorshub | 09/13/2021 11:36:55 AM |
AbbVie And REGENXBIO Announce Eye Care Collaboration; AbbVie | crudeoil24 | investorshub | 09/13/2021 11:27:19 AM |
https://www.google.com/amp/s/www.nasdaq.com/article/4-gene-therapy-players-likel | StockLearner2011 | investorshub | 06/03/2019 1:00:24 PM |
I believe the buyout is in a distance | StockLearner2011 | investorshub | 05/31/2019 12:31:48 PM |
is there an argument for a BO? https://msmoneymoves.com/2019/05/28/could-this-bi | Zmill | investorshub | 05/29/2019 1:41:40 AM |
Strong buy @ 50!!!! | BlackEyePatch | investorshub | 05/25/2019 2:14:25 AM |
RGNX buy 66.90 | stocktrademan | investorshub | 08/23/2018 5:16:34 PM |
Hope no more form 4s for insider selling | StockLearner2011 | investorshub | 04/19/2018 7:15:52 PM |
Lets see how tomorrow will be | StockLearner2011 | investorshub | 04/19/2018 7:12:05 PM |
Why insiders sold at $34 and $37 while | StockLearner2011 | investorshub | 04/19/2018 7:10:44 PM |
$45 soon! Yummy | StockLearner2011 | investorshub | 04/17/2018 3:24:38 PM |
RGNX bullish 14.39 | stocktrademan | investorshub | 10/04/2016 3:57:30 PM |
Agreed, would like to to see the stock | protagonist12 | investorshub | 06/06/2016 10:52:46 PM |
Interesting play here for the long term. Very | floWteiuQ | investorshub | 05/16/2016 4:19:00 PM |
$RGNX no bid support, too early still, listed VC... | protagonist12 | investorshub | 10/25/2015 8:52:29 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-05-13 17:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
REGENXBIO Reports First Quarter 2024 Financial Results and Recent Operational Highlights PR Newswire Company remains on track for its first BLA filing in 2024 and is accelerating progress toward pivotal trial initiation for Duchenne (H2 2024) and diabetic retinopathy (H1 202...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...